Clinical trials
Active, not recruiting Phase 2 Prostatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
113 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 6 |
| 2017 | 11 |
| 2018 | 15 |
| 2019 | 12 |
| 2020 | 14 |
| 2021 | 16 |
| 2022 | 10 |
| 2023 | 7 |
| 2024 | 7 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 113 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 10 |
| M.D. Anderson Cancer Center | 8 |
| National Cancer Institute (NCI) | 8 |
| H. Lee Moffitt Cancer Center and Research Institute | 5 |
| Jonsson Comprehensive Cancer Center | 5 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 5 |
| CHU de Quebec-Universite Laval | 4 |
| Canadian Cancer Trials Group | 3 |
| University of Wisconsin, Madison | 3 |
| ECOG-ACRIN Cancer Research Group | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 113 |
| Breast Neoplasms | 5 |
| Colorectal Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Ovarian Neoplasms | 3 |
| Endometrial Neoplasms | 2 |
| Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Rectal Neoplasms | 2 |
| Stomach Neoplasms | 2 |
Trials
Showing 1 to 25 of 113. Each trial links to its page on Pharma Observatory.
13 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.